Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf266 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Eric A F Simões und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado Aurora, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization, Metapneumovirus, Paramyxoviridae Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Among older adults, respiratory syncytial virus (RSV) infection is a known cause of hospitalization, intensive care unit (ICU) admission, and mortality risk. The severity of the disease burden of human metapneumovirus (HMPV) among older adults is less well recognized. The objective of this study was to better understand risk factors for hospitalization with and outcomes in adults ≥50 years of age infected with HMPV and to compare these with RSV risk factors and outcomes.
Methods
This was a retrospective cohort analysis of adults 50–88 years of age in 93 medical facilities in the Colorado Hospital Association database between 2016 and 2023. RSV and HMPV, other respiratory infections, and comorbidities were identified using International Classification of Diseases, Tenth Revision codes and grouped by increasing numbers of comorbidities. Multivariate logistic regression was performed to estimate the risk of the various predictors on ICU admission, and mortality for both HMPV and RSV infection, adjusted for sex, age, and comorbidity.
Results
The highest risk for ICU admission was chronic obstructive pulmonary disease (COPD) (RSV: adjusted odds ratio [aOR], 2.24 [95% confidence interval {CI}, 1.81–2.77], P < .001; HMPV: aOR, 2.99 [95% CI, 2.13–4.19], P < .001), and those with neuromuscular disease without dementia (RSV: aOR, 2.33 [95% CI, 1.98–2.75], P < .001; HMPV: aOR, 2.22 [95% CI, 1.75–2.80], P < .001). Age significantly increased the odds of mortality among RSV-infected but not HMPV-infected patients. Neurological disorders with dementia were the highest comorbid risk factor for RSV mortality (aOR, 4.16 [95% CI, 3.01–5.77]; P < .001), in contrast to COPD for HMPV mortality (aOR, 12.44 [95% CI, 3.02–51.17]; P < .001).
Conclusions
HMPV infection poses a unique disease burden with specific high-risk comorbidities among the older adult population distinct from that of RSV and warrants further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado Aurora, Aurora, Colorado, USA.
- Samshoma Medical Research Inc, Denver, Colorado, USA.
- Alpha Level Consultants, Nagpur, Maharashtra, India.
ORCID-Profile: Robert J Suss
Zitieren
APA
Simões, E. A. F., Suss, R. J., & Raje, D. (2025). Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf266
Vancouver
Simões EAF, Suss RJ, Raje D. Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf266
BibTeX
@article{Simes2025,
author = {Simões, Eric A F and Suss, Robert J and Raje, Dhananjay},
title = {Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf266}
}
EUVIMED